Harrow completes acquisiton of Melt Pharmaceuticals | Ophthalmology Times – Clinical Insights for Eye Specialists
Harrow Completes Melt Pharmaceuticals Acquisition to Advance Ophthalmology In a strategic move set to reshape the landscape of ophthalmic care, Harrow, a leading eyecare pharmaceutical company, has officially announced the completion of its acquisition of Melt Pharmaceuticals, Inc. This pivotal transaction, finalized in early October 2024, marks a significant step in Harrow’s mission to build […]
